HK1068277A1 - Pharmaceutical compositions comprising chelidonineor derivatives thereof - Google Patents

Pharmaceutical compositions comprising chelidonineor derivatives thereof

Info

Publication number
HK1068277A1
HK1068277A1 HK05100568A HK05100568A HK1068277A1 HK 1068277 A1 HK1068277 A1 HK 1068277A1 HK 05100568 A HK05100568 A HK 05100568A HK 05100568 A HK05100568 A HK 05100568A HK 1068277 A1 HK1068277 A1 HK 1068277A1
Authority
HK
Hong Kong
Prior art keywords
chelidonineor
derivatives
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
HK05100568A
Other languages
English (en)
Inventor
Jae-Soon Eun
Yong-Geun Kwak
Dae-Keun Kim
Soo-Wan Chae
Original Assignee
Eun Jae Soon
Kwak Yong Geun
Kim Dae Keun
Chae Soo Wan
Jung Young Hoon
Yee Ok Pyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eun Jae Soon, Kwak Yong Geun, Kim Dae Keun, Chae Soo Wan, Jung Young Hoon, Yee Ok Pyo filed Critical Eun Jae Soon
Publication of HK1068277A1 publication Critical patent/HK1068277A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HK05100568A 2001-05-11 2005-01-21 Pharmaceutical compositions comprising chelidonineor derivatives thereof HK1068277A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20010025706 2001-05-11
PCT/KR2002/000865 WO2002092085A1 (en) 2001-05-11 2002-05-09 Pharmaceutical compositions comprising chelidonine or derivatives thereof

Publications (1)

Publication Number Publication Date
HK1068277A1 true HK1068277A1 (en) 2005-04-29

Family

ID=36747912

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100568A HK1068277A1 (en) 2001-05-11 2005-01-21 Pharmaceutical compositions comprising chelidonineor derivatives thereof

Country Status (6)

Country Link
US (1) US6887882B2 (ko)
JP (1) JP2004536802A (ko)
KR (1) KR100545930B1 (ko)
CN (1) CN1254243C (ko)
HK (1) HK1068277A1 (ko)
WO (1) WO2002092085A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1685134B1 (de) * 2003-11-05 2009-02-11 Salama, Zoser B. nat.rer.Dr. Neue chelidonin-derivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen
US7833805B2 (en) * 2004-10-21 2010-11-16 University Of Cincinnati Selectively permeable membranes on porous substrates
KR100716768B1 (ko) * 2005-09-26 2007-05-14 우석대학교 산학협력단 데쿠르신을 유효성분으로 하는 부정맥의 예방 및 치료용조성물, 및 그 제조방법
KR100715887B1 (ko) * 2006-11-27 2007-05-09 우석대학교 산학협력단 부정맥의 예방용 기능성 식품
EP2627876B1 (en) 2010-10-14 2015-03-11 Energreen Heat Recovery AS Method and system for the utilization of an energy source of relatively low temperature
CN113372355B (zh) * 2021-05-13 2023-02-17 山东大学 六氢苯并菲啶类生物碱及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769452A (en) * 1986-02-07 1988-09-06 Vipont Laboratories, Inc. Production of purity benzo-c-phenanthridine alkaloid salts
US4737503A (en) * 1986-10-08 1988-04-12 Vipont Laboratories, Inc. Method for inhibiting the release of histamine
JPH11302174A (ja) * 1998-04-23 1999-11-02 Maruho Co Ltd 細胞接着阻害剤
AU2864100A (en) * 1999-02-01 2000-08-18 Cytovia, Inc. Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products
CN1237418A (zh) * 1999-06-09 1999-12-08 刘德夫 止痛药物血草素及其制备方法

Also Published As

Publication number Publication date
CN1516583A (zh) 2004-07-28
US6887882B2 (en) 2005-05-03
WO2002092085A1 (en) 2002-11-21
JP2004536802A (ja) 2004-12-09
KR100545930B1 (ko) 2006-01-25
CN1254243C (zh) 2006-05-03
US20040097533A1 (en) 2004-05-20
KR20040007539A (ko) 2004-01-24

Similar Documents

Publication Publication Date Title
HK1072200A1 (en) Pro-micelle pharmaceutical compositions
GB0111597D0 (en) Pharmaceutical compositions
EP1450824A4 (en) PHARMACEUTICAL COMPOSITION
GB0019028D0 (en) Pharmaceutical compositions
EP1407785A4 (en) MEDICAL COMPOSITIONS
HK1065944A1 (en) Medicinal compositions
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
HUP0400850A3 (en) Oral pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
EP1408896A4 (en) PHARMACEUTICAL COMPOSITION
GB0129117D0 (en) Pharmaceutical composition
AU1390002A (en) Pharmaceutical compositions
HK1068277A1 (en) Pharmaceutical compositions comprising chelidonineor derivatives thereof
GB0008485D0 (en) Pharmaceutical compositions
GB0116107D0 (en) Pharmaceutical composition
GB0009613D0 (en) Pharmaceutical compositions
GB0104752D0 (en) Pharmaceutical compositions
GB0127805D0 (en) Pharmaceutical composition
PL370037A1 (en) Pharmaceutical composition
GB2382302B (en) Pharmaceutical compositions
IL157411A0 (en) Pharmaceutical composition
EP1413314A4 (en) MEDICAL COMPOSITIONS

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100509